A cutting-edge center dedicated to digital and robotic surgery
LONDON, November 9, 2021 / PRNewswire / – Smith + Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces its first dedicated medical education center to help clients across the Asia Pacific Region.
Strategically located in Singapore, the center will support the safe and effective use of Smith + Nephew products as well as the professional development of healthcare professionals across the region. It should be operational by mid-2022.
The center will have a strong focus on digital and robotic surgery, with Smith + Nephew’s Real Intelligence product ecosystem, as well as training support across all product portfolios including orthopedic reconstruction, sports medicine, ears, nose and throat and advanced wound management.
Healthcare professionals will benefit from digital training technology, including interactive LED screens, augmented and virtual reality, and the convenient digital operating room experience. A specially designed digital application will integrate all aspects of the learning journey, including allowing participants to design their own agenda, register for upcoming events, perform contactless check-in, book virtual reality sessions or augmented and access Smith + Nephew’s learning management training modules. system, Education Unlimited.
Smith + Nephew APAC President, Myra Eskes commented, “We are delighted to establish a world-class training center in the region that will encompass a seamless end-to-end learning journey for our healthcare professional clients from around the world. Asia Pacific Region. Aligned with our corporate purpose and strategic business objectives, this next-generation center will be essential for delivering engaging, immersive and interactive training as well as moving our business forward. “
Supporting Smith + Nephew’s Life Unlimited goal, the Medical Education Center, together with the app and Education Unlimited, aims to enhance the learning journey for healthcare professionals to achieve the best patient outcomes. The new installation of Singapore is the latest addition to Smith + Nephew’s global network which includes centers owned by Europe and the United States.
About Smith + Neveu
Smith + Nephew is a portfolio medical technology company that exists to restore people’s bodies and self-confidence by using technology to push the boundaries of life. We call this goal “Life Unlimited”. Our 18,000 employees accomplish this mission every day, making a difference in the lives of patients through the excellence of our product portfolio, and the invention and application of new technologies in our three global orthopedics franchises. , advanced wound management, sports medicine and ENT.
Founded in Hull, United Kingdom, in 1856, we now operate in over 100 countries and generate annual sales of 4.6 billion dollars in 2020. Smith + Nephew is part of the FTSE100 (LSE: SN, NYSE: SNN). The terms “Group” and “Smith + Nephew” are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
This document may contain forward-looking statements which may or may not prove to be correct. For example, statements regarding expected revenue growth and trading margins, market trends and our product portfolio are forward-looking statements. Expressions such as “aim”, “plan”, “intend”, “anticipate”, “well placed”, “believe”, “estimate”, “‘expect”, “target”, “consider” and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith + Nephew, these factors include: risks associated with the impact of COVID-19, such as the depth and longevity of its impact, government actions and other restrictive measures taken in response, significant delays and cancellations of elective procedures, reduced capacity of procedures at medical facilities, restricted access of sales representatives to medical facilities or our ability to execute business continuity plans due to COVID-19; economic and financial conditions in the markets we serve, particularly those affecting healthcare providers, payers and clients (including, without limitation, as a result of COVID-19); the price levels of established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or non-compliance with related regulations; litigation relating to patents or other claims; legal compliance risks and associated investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, due to COVID-19); competition for qualified personnel; strategic actions, including acquisitions and divestitures, our success in exercising due diligence, valuation and integration of acquired businesses; disruptions that may result from transactions or other changes we make to our business plans or organization to adapt to changing market conditions; and many other matters that affect us or our markets, including those of a political, economic, commercial, competitive or reputational nature. Please see documents that Smith + Nephew has filed with the United States Securities and Exchange Commission under the US Securities Exchange Act of 1934, as amended, including Smith + Nephew’s most recent annual report on the Form 20-F, for a discussion of some of these factors. Any forward-looking statement is based on information available to Smith + Nephew at the date of the statement. All written or oral forward-looking statements attributable to Smith + Nephew are qualified by this cautionary statement. Smith + Nephew assumes no obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith + Nephew’s expectations.
™ Trademark of Smith + Nephew. Certain trademarks have been registered with the US Patent and Trademark Office.
View original content to download multimedia:https://www.prnewswire.com/news-releases/smithnephew-establishes-its-first-medical-education-centre-for-the-asia-pacific-region-in-singapore-301420489.html
SOURCE Smith & Nephew plc